JOT Automation Ltd, Press Release, 11 February 2014
JOT Automation, the leading supplier of test and production solutions, and Tensor ID Inc., specialists in machine vision solutions, will highlight the benefits of its combined service and technology offering at ATX West as the companies exhibit together for the first time.
Jorma Venäläinen, Business Line Director of Life Sciences at JOT Automation, says: “JOT and Tensor ID are planning to join forces, and have started to co-develop a fully automated solution for the quality assurance of auto-injector syringes. Together we are pre-promoting an auto injection syringe inspection platform. The vision based platform enables inspection of silicone coating inside glass syringes.”
“The quality of silicone oil and its distribution on the inner syringe surface are two important factors that affect the injection performance of auto-injector devices. To better identify and screen out syringes with insufficient or non-uniform silicone oil distribution, our new technology visualizes, quantifies and analyses silicone oil distribution.”
Stacey Swall from Tensor ID added: “By combining Tensor ID’s expertise in the latest machine vision components, algorithms and visualization techniques and JOT’s extensive knowledge of test and production solutions, we are confident to enter the fast growing market. In fact the market for auto-injectors is set to rise to 1.07 billion dollars by 2015. In addition we see possibilities to exploit this technology for quality inspection of pipettes, vials and tubes.”
With its mass production know-how, originating from the telecom industry, JOT Automation is becoming a leading name in the medical device industry and the company has designed a number of platforms currently being used in the life science industry. The collaboration with Tensor ID is a strategical step forward in offering solutions for the automated production of medical and healthcare devices and consumables.
Visit JOT Automation and Tensor ID at ATX West, Booth 4643, Anaheim CA 11-13th February.